These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20603623)

  • 1. Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome.
    Ikezoe T; Takeuchi A; Taniguchi A; Togitani K; Yokoyama A
    Bone Marrow Transplant; 2011 Apr; 46(4):616-8. PubMed ID: 20603623
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
    Ikezoe T; Togitani K; Komatsu N; Isaka M; Yokoyama A
    Bone Marrow Transplant; 2010 Apr; 45(4):783-5. PubMed ID: 19718058
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation.
    Ikezoe T; Takeuchi A; Chi S; Takaoka M; Anabuki K; Kim T; Sakai M; Taniguchi A; Togitani K; Yokoyama A
    Eur J Haematol; 2013 Nov; 91(5):442-7. PubMed ID: 23952647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin.
    Sakai M; Ikezoe T; Bandobashi K; Togitani K; Yokoyama A
    Bone Marrow Transplant; 2010 Apr; 45(4):803-5. PubMed ID: 19767779
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of refractory acute GVHD complicated by severe intestinal transplant-associated thrombotic microangiopathy using recombinant thrombomodulin.
    Inoue Y; Kosugi S; Miura I; Hatta Y; Takeuchi J
    Thromb Res; 2011 Jun; 127(6):603-4. PubMed ID: 21262525
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human soluble thrombomodulin for the treatment of hepatic sinusoidal obstructive syndrome post allogeneic hematopoietic SCT.
    Nakamura D; Yoshimitsu M; Kawada H; Inoue H; Kuroki T; Kaieda T; Fujino S; Hamada H; Suzuki S; Matsushita K; Uozumi K; Arima N
    Bone Marrow Transplant; 2012 Mar; 47(3):463-4. PubMed ID: 21552299
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral marginal keratitis associated with engraftment syndrome after hematopoietic stem cell transplantation.
    Dai E; Couriel D; Kim SK
    Cornea; 2007 Jul; 26(6):756-8. PubMed ID: 17592333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic veno-occlusive disease with severe capillary leakage after peripheral stem cell transplantation: treatment with recombinant plasminogen activator and C1-esterase inhibitor concentrate.
    Heying R; Nürnberger W; Spiekerkötter U; Göbel U
    Bone Marrow Transplant; 1998 May; 21(9):947-9. PubMed ID: 9613790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous response to recombinant thrombomodulin by grade of sinusoidal obstructive syndrome after pediatric stem cell transplantation.
    Inagaki J; Kurauchi K; Fukano R; Noguchi M; Okamura J
    Bone Marrow Transplant; 2016 Nov; 51(11):1543-1545. PubMed ID: 27376445
    [No Abstract]   [Full Text] [Related]  

  • 10. Engraftment syndrome following hematopoietic stem cell transplantation.
    Spitzer TR
    Bone Marrow Transplant; 2001 May; 27(9):893-8. PubMed ID: 11436099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinus bradycardia associated with cyclosporine following allogeneic hematopoietic stem cell transplantation.
    Fujisaki G; Kami M; Murashige N; Kishi Y; Inokuchi C; Tanosaki R; Momomura S
    Bone Marrow Transplant; 2005 Jan; 35(2):211-2. PubMed ID: 15531900
    [No Abstract]   [Full Text] [Related]  

  • 12. Extramedullary relapse of therapy-related myelodysplastic syndrome after donor leukocyte infusion.
    Chao MM; Kontny U; Brink I; Göhring G; Schmitt-Gräff A; Rister M; Strahm B
    Ann Hematol; 2008 Feb; 87(2):165-6. PubMed ID: 17805535
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small intestinal CMV disease detected by capsule endoscopy after allogeneic hematopoietic SCT.
    Kakugawa Y; Kim SW; Takizawa K; Kikuchi T; Fujieda A; Waki F; Fukuda T; Saito Y; Shimoda T; Takaue Y; Saito D
    Bone Marrow Transplant; 2008 Aug; 42(4):283-4. PubMed ID: 18500371
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with recombinant human soluble thrombomodulin.
    Sakai M; Ikezoe T; Bandobashi K; Yokoyama A
    Thromb Res; 2010 Nov; 126(5):e392-3. PubMed ID: 20656332
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiopathic hyperammonaemia syndrome following allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT).
    Ho AY; Mijovic A; Pagliuca A; Mufti GJ
    Bone Marrow Transplant; 1997 Dec; 20(11):1007-8. PubMed ID: 9422485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of hepatic sinusoidal obstructive syndrome after hematopoietic stem cell transplantation in a child using recombinant thrombomodulin.
    Yamamoto S; Yagawa A; Toyama D; Akiyama K; Hayashi M; Mabuchi M; Shimizu T; Ikeda H; Isoyama K
    Acta Haematol; 2013; 129(1):62-4. PubMed ID: 23147560
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome.
    Ho AY; Adams S; Shaikh H; Pagliuca A; Devereux S; Mufti GJ
    Bone Marrow Transplant; 2002 May; 29(10):867-9. PubMed ID: 12058237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indication and results of hematopoietic stem cell transplantation. 3. Aplastic anemia and myelodysplastic syndrome].
    Sakamaki H
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1477-82. PubMed ID: 9780674
    [No Abstract]   [Full Text] [Related]  

  • 20. Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia.
    Bitan M; Or R; Shapira MY; Resnick IB; Gesundheit B; Ackerstein A; Samuel S; Elad S; Slavin S
    Bone Marrow Transplant; 2008 Jan; 41(1):69-78. PubMed ID: 17994125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.